NEUROCOGNITIVE DISORDERS
Clinical trials for NEUROCOGNITIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROCOGNITIVE DISORDERS trials appear
Sign up with your email to follow new studies for NEUROCOGNITIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Alzheimer's drug study halted early: what happened?
Disease control TerminatedThis study looked at the long-term safety and effects of a drug called XPro1595 in people with Alzheimer's disease who had already taken it in earlier studies. Only 11 people took part, and the study was stopped early. The main goal was to check for side effects and see if the dr…
Matched conditions: NEUROCOGNITIVE DISORDERS
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New tablet tool aims to give voice to dementia patients
Symptom relief TerminatedThis study tested a personalized touchscreen device (My PATI) to help people with Alzheimer's or related dementias communicate their care preferences. Researchers worked with 42 participants (people with dementia and their caregivers) to see if the device improved quality of life…
Matched conditions: NEUROCOGNITIVE DISORDERS
Phase: NA • Sponsor: Florida International University • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC